Das Krankheitsverständnis der Homöopathie bei George Vithoulkas: die Gesundheitsebenen

Zusammenfassung

Es wird ein Klassifikationssystem vorgestellt, das das Krankheitsverständnis verbessern und prognostische Aussagen ermöglichen soll. Mit einer solchen Einteilung kann der Allgemeinzustand des Patienten bestimmt und neben der Prognose die akute Symptomatik eingeordnet und sogar die zu erwartende Mittelreaktion interpretiert werden. Das System und die Parameter, die für die Bestimmung der Gesundheitsebene, auf der sich ein Patient befindet, anwendbar sind, werden dargestellt und diskutiert.

Summary

To understand disease states and prognosis of a patient a classification system of levels of health is proposed. Such a system may enable to evaluate the patient’s general condition, prognosis, the manifesting symptomatology and even the expected remedy reaction. The system and parameters that define the level of health to which a patient belongs are being presented and discussed.

Schlüsselwörter

Krankheitsverständnis - Gesundheitsebene - Prognose - Systematik - Arzneimittelwirkung

Keywords

Evaluation of disease - levels of health - prognosis - classification - remedy reaction

• Literatur

• 1 Ahkee S, Srinath L, Ramirez J. Community-acquired pneumonia in the elderly: association of mortality with lack of fever and leukocytosis. South Med J 1997; 90(3): 296-298
• 2 Aliouat-Denis CM et al. Pneumocystis species, co-evolution and pathogenic power. Infection, Genetics & Evolution 2008; 8(5): 708-726
• 3 Barry JM. The Great Influenza: The epic Story of the deadliest Plague in History. New York: Viking Penguin; 2004
• 4 Benviste R, Davies J. Mechanisms of antibiotic resistance in bacteria. Ann Rev Biochem 1973; 42: 471
• 5 Curran LK, Newschaffer CJ, Lee LC et al. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics 2007; 120(6) e1386–1392
• 6 Fine JD et al. Epidermolysis Bullosa: Clinical, epidemiologic, and laboratory Advances, and the Findings of the National Epidermolysis Bullosa Registry. Baltimore: Johns Hopkins Univ Press; 1999
• 7 Fine J, Johnson L, Weiner M, Suchindran C. Cause-specific Risks of Childhood Death in Inherited Epidermolysis Bullosa. The Journal of Pediatrics 2008; 152(2): 276-280
• 8 Forget BG, Cohen AR. Thalassemia syndromes. In: Hoffman R, Benz EJ, Shattil SS, et al., eds. Hematology: Basic Principles and Practice. Chapter 35. 4th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2005
• 9 Hummel RP et al. Antibiotic resistance transfer from nonpathogenic to pathogenic bacteria. Surgery 1977; 82(3): 382-385
• 10 Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918–1920 „Spanish“ influenza pandemic. Bull Hist Med 2002; 76(1): 105-115
• 11 Korfhagen TR, Loper JC, Ferrel JA. Pseudomonas aeruginosa R factors determining gentamicin plus carbenicillin resistance from patients with urinary tract colonizations. Antimicrob Agents Chemother 1974; 6: 492
• 12 Naudin J, Mège JL, Azorin JM, Dassa D. Elevated circulating levels of IL-6 in schizophrenia. Schizophr Res 1996; 20(3): 269-273
• 13 Norman DC. Fever in the elderly. Clin Infect Dis 2000; 31(1): 148-151
• 14 Simonsen L, Clarke MJ, Schonberger LB et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178: 53-60
• 15 Stollerman GH. Trends in bacterial virulence and antibiotic susceptibility: streptococci, pneumonococci and gonococci. Ann Int Med 1978; 89(part 2): 746-748
• 16 Torres AR. Is fever suppression involved in the etiology of autism and neurodevelopmental disorders?. BMC Pediatr 2003; 3: 9
• 17 Vithoulkas G. A new model for health and disease. Chapter 14: Predispositions. Berkeley: North Atlantic Books; 1991
• 18 Vithoulkas G. A new model for health and disease. Berkeley: North Atlantic Books; 1991: 54-60